Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (281-290 of 561) with videos related to

Pageof 57
Sort By:
BJU International|April 16, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancerEkaterina Laukhtina, Paolo Gontero, Marko Babjuk, et al.
BJU International|June 1, 2026
Complications following repeated ureteroscopy for UTUC: The price to pay for nephron-sparing surgeryPietro Scilipoti, Angelo Occhi, Daniele Robesti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder CancerValentina Tateo, Joep J de Jong, Antonio Cigliola, et al.
Minerva Urology and Nephrology|December 21, 2023
Perioperative and oncological outcomes of distal ureter management during nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysisAndrea Gallioli, Michael Baboudjian, Pietro Diana, et al.
Urologic Oncology|June 6, 2022
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362Francesco Soria, Ilaria Lucca, Marco Moschini, et al.
Urologic Oncology|October 3, 2015
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groupsNazareno Suardi, Paolo Dell'Oglio, Andrea Gallina, et al.
Urologic Oncology|March 27, 2017
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancerFrancesco Soria, Ilaria Lucca, Marco Moschini, et al.
Andrology|August 3, 2020
Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: A review of the literatureLuca Afferi, Jürgen Pannek, Arthur Louis Burnett, et al.
World Journal of Urology|December 31, 2024
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
European Urology Oncology|November 8, 2020
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysisRiccardo Tellini, Andrea Mari, Gianluca Muto, et al.
Pageof 57

Showing results (281-290 of 561) with videos related to

Sort By:
Pageof 57
BJU International|April 16, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancerEkaterina Laukhtina, Paolo Gontero, Marko Babjuk, et al.
BJU International|June 1, 2026
Complications following repeated ureteroscopy for UTUC: The price to pay for nephron-sparing surgeryPietro Scilipoti, Angelo Occhi, Daniele Robesti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder CancerValentina Tateo, Joep J de Jong, Antonio Cigliola, et al.
Minerva Urology and Nephrology|December 21, 2023
Perioperative and oncological outcomes of distal ureter management during nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysisAndrea Gallioli, Michael Baboudjian, Pietro Diana, et al.
Urologic Oncology|June 6, 2022
Corrigendum to < Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer>, urologic oncology: Seminars and original investigations volume 35, issue 6, June 2017, pages 356-362Francesco Soria, Ilaria Lucca, Marco Moschini, et al.
Urologic Oncology|October 3, 2015
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groupsNazareno Suardi, Paolo Dell'Oglio, Andrea Gallina, et al.
Urologic Oncology|March 27, 2017
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancerFrancesco Soria, Ilaria Lucca, Marco Moschini, et al.
Andrology|August 3, 2020
Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: A review of the literatureLuca Afferi, Jürgen Pannek, Arthur Louis Burnett, et al.
World Journal of Urology|December 31, 2024
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
European Urology Oncology|November 8, 2020
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysisRiccardo Tellini, Andrea Mari, Gianluca Muto, et al.
Pageof 57